{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:40:07Z","timestamp":1746344407624,"version":"3.40.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Acquired hemophilia A (AHA) is a rare bleeding disorder with prolonged activated partial thromboplastin time (aPTT). Severe hemorrhage may occur, especially in refractory AHA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported a 63-year-old man who suffered from life-threatening bleeding after the onset in lower limbs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was diagnosed as AHA which was related to pemphigoid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient had no response to the first-line treatment with corticosteroid and cyclophosphamide. Meanwhile, fatal hemorrhage occurred successively in thoracic cavity and right frontal lobe. rFVIIa and rituximab were administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient survived from the life-threatening hemorrhage with a normal aPTT. His aPTT and FVIII:C level was normal during the follow-up of 6 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Rituximab and rFVIIa can play a critical role in rescuing AHA that is refractory to the first-line treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024025","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T13:37:19Z","timestamp":1611409039000},"page":"e24025","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa"],"prefix":"10.1097","volume":"100","author":[{"given":"Hongbing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"R3-20250504","first-page":"86","article-title":"Management of severe hemorrhage and inhibitor elimination in acquired hemophilia: the modified Heidelberg-Malm\u00f6 protocol","volume":"88","author":"Huth-K\u00fchne","year":"2003","journal-title":"Haematologica"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2516.2007.01450.x","article-title":"ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay","volume":"13","author":"Sahud","year":"2007","journal-title":"Haemophilia"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth-K\u00fchne","year":"2009","journal-title":"Haematologica"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2003-11-4075","article-title":"Selective B, cell depletion with rituximab for the treatment of patients with acquired hemophilia","volume":"103","author":"Stasir","year":"2004","journal-title":"Blood"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors","volume":"112","author":"Franchini","year":"2008","journal-title":"Blood"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.autrev.2010.11.005","article-title":"Acquired hemophilia A: diagnosis, aetiology, clinical spectrum and treatment options","volume":"10","author":"Shetty","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1573397113666170519121952","article-title":"Acquired hemophilia as initial presentation in a patient with systemic lupus erythematosus","volume":"13","author":"Khodamoradi","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/MBC.0b013e3283646635","article-title":"Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report","volume":"24","author":"Drobiecki","year":"2013","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:00:40Z","timestamp":1746342040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024025"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024025","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2020-02-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}